SYDRA
AI-assisted novel geroprotectors discovery and in vivo testing. Translation into longevity supplements and anti-aging drugs.
SYDRA
Social Links:
Industry:
Bioinformatics Biopharma Biotechnology Life Science
Founded:
2024-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.sydra.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Cloudflare Hosting
Similar Organizations
Bio4Dreams
Bio4Dreams is a privately funded certified incubator for innovative startups in very early stage phase, dedicated to Life Sciences.
BioMathematica
Biomathematica is a biotech start-up providing a high level modeling service to characterize and understand a biological process.
BioRegenx
BioRegenx is a healthcare company that sells and markets patented nutraceutical dietary supplements and medical imaging devices.
Duke Street Bio
Duke Street Bio develops medical drugs intended to provide improved treatment to cancer patients.
Juno Bio
Juno Bio is a biotechnology company that uses machine learning and bioinformatics to analyse and predict how best to manipulate microbiomes.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
RheoDx
A precise and portable in-vitro device that brings efficiency to the hematological diseases diagnostics with a single blood drop.
Ten Bio
Ten Bio is a biotechnology company that provides ex vivo skin culture for research and lab testing.
VitroScan
VitroScan is dedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients.
Current Employees Featured
Founder
Investors List
EWOR
EWOR investment in Convertible Note - SYDRA
Official Site Inspections
http://www.sydra.bio Semrush global rank: 7.89 M Semrush visits lastest month: 754
- Host name: 172.67.173.87
- IP address: 172.67.173.87
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SYDRA"
SYDRA Biotech
At SYDRA (SYnthetic DRug Algorithms) we utilize proprietary written and trained ANNs to develop novel geroprotectors, and test them in vivo.See details»
SYDRA - Crunchbase Company Profile & Funding
Who invested in SYDRA? SYDRA is funded by EWOR. When was the last funding round for SYDRA? SYDRA closed its last funding round on Jan 22, โฆSee details»
SYDRA - LinkedIn
SYDRA (SYnthetic DRug Algorithms). AI-assisted novel geroprotectors discovery and their in vivo efficacy confirmation. Primary focus - biogerontology.See details»
SYDRA won business development grant (stage I) - SYDRA
On December 5th 2023 team SYDRA won business development grant (stage I) at venturekick.ch and got invitation for stage II competition among other winners. AI-assisted geroprotectors โฆSee details»
General - SYDRA
Sydra has been selected, along with other promising young biotech startups, to participate in Swiss Biotech Day 2024 (April 22-23, 2024 โ Congress Center Basel, Switzerland).See details»
Alexander Dakhovnik โ Co-Founder โ SYDRA | LinkedIn
CSO/CEO & founder of SYDRA (SYnthetic DRug Algorithms) · PhD in molecular biology. Biogerontologist, work in the aging/longevity field. Area of research: novel geroprotectors โฆSee details»
SYDRA - Funding, Financials, Valuation & Investors - Crunchbase
Jan 22, 2024 SYDRA has raised 1 round. This was a Convertible Note round raised on Jan 22, 2024. SYDRA is funded by EWOR.See details»
SYDRA - VentureRadar
The task of SYDRA is to develop systematically and on large-scale drugs able to increase health- and lifespan (called geroprotectors). SYDRA deploys a feedback-based AI-driven drug โฆSee details»
SYDRA AG - Venture Kick
SYDRA AG: SYDRA is a Biotech startup developing preclinical drug candidates for age-associated diseases using a proprietary AI-driven, phenotype-first approach (Hit-to-Target โฆSee details»
SYDRA - Crunchbase
AI-assisted novel geroprotectors discovery and in vivo testing. Translation into longevity supplements and anti-aging drugs.See details»
SYDRA 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for SYDRA. Use the PitchBook Platform to explore the full profile.See details»
SYDRA - Products, Competitors, Financials, Employees, โฆ
SYDRA is a biotechnology company focused on the discovery and development of geroprotectors, drugs that aim to prolong health and lifespan. The company utilizes advanced โฆSee details»
SYDRA will participate in the world's largest longevity conference ...
Jul 2, 2024 SYDRA will participate in the worldโs largest longevity conference, ARDD 2024, in Copenhagen, Denmark. We will present our work and latest achievements on August 29th, โฆSee details»
SYDRA AG - startup.ch
SYDRA is a Biotech startup developing preclinical drug candidates for age-associated diseases using a proprietary AI-driven, phenotype-first approach (Hit-to-Target method).See details»
SYDRA Overview | SignalHire Company Profile
SYDRA (SYnthetic DRug Algorithms). AI-assisted novel geroprotectors discovery. Primary focus - biogerontology.See details»
SYDRA - Updates, News, Events, Signals & Triggers - Crunchbase
Jan 22, 2024 AI-assisted novel geroprotectors discovery and in vivo testing. Translation into longevity supplements and anti-aging drugs.See details»
Sydra Bio (Sydra Bio) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
ไบ่งฃSydra Bio (Sydra Bio)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
SYDRA - Contacts, Employees, Board Members, Advisors & Alumni
AI-assisted novel geroprotectors discovery and in vivo testing. Translation into longevity supplements and anti-aging drugs.See details»
News - SYDRA
News Explore breakthroughs in anti-aging research, witness revolutionary therapies in action, and stay informed on the latest advancements redefining the possibilities of human lifespan.See details»
New survey: U.S. biotechs warn tariffs could impede access to โฆ
2 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the โฆSee details»